alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
In the

Court of Appeals

Second Appellate District of Texas

at Fort Worth

No. 02-16-00050-CV

RICHARD SEIM AND LINDA SEIM,

Appellants

V.

ALLSTATE TEXAS LLOYDS AND LISA 

SCOTT, Appellees

§

§

§

§

§

On Appeal from the 141st District Court

of Tarrant County (141-270531-14)

July 30, 2019

Opinion by Justice Gabriel

Dissent by Chief Justice Sudderth

JUDGMENT ON REMAND AND ON EN BANC RECONSIDERATION

This court has considered the record on appeal in this case and holds that there 

was no reversible error in the trial court’s judgment. It is ordered that the judgment 

of the trial court is affirmed. 

It is further ordered that appellants Richard Seim and Linda Seim shall bear the 

costs of this appeal, for which let execution issue. 

SECOND DISTRICT COURT OF APPEALS 

By /s/ Lee Gabriel

 Justice Lee Gabriel
EXHIBIT 32.1
                                  ------------

     CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO
                                   SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002
                        ---------------------------------


The undersigned hereby certifies,  pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002 (18 U.S.C. 1350), that, to the best of my knowledge:

1.   The Quarterly Report on Form 10-Q of Cumberland Technologies,  Inc. for the
     period  ended  September  30,  2003 as filed  November  14,  2003  with the
     Securities and Exchange Commission, fully complies with the requirements of
     Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.   The information  contained in the quarterly report fairly presents,  in all
     material  respects,  the  financial  condition and results of operations of
     Cumberland Technologies, Inc.




Dated:  November 14, 2003            By:  /s/ Joseph M. Williams
                                     -------------------------------------------
                                     Joseph M. Williams, President and Treasurer
                                     of Cumberland Technologies, Inc.
Exhibit 31.2

I, Michael A. Angerthal, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Virtus Investment Partners, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report;

4. The registrants other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the
registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal control over financial reporting; and

5. The registrants
other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons
performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants
internal control over financial reporting.

Date: August 13, 2009



|                        
|------------------------
|/s/ MICHAEL A. ANGERTHAL
|Michael A. Angerthal    
|Chief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5

<S>                                        <C>
<PERIOD-TYPE>                              12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                         278,134
<SECURITIES>                                26,837,640
<RECEIVABLES>                                  193,934
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            27,348,772
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              27,348,772
<CURRENT-LIABILITIES>                          599,470
<BONDS>                                              0
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                  26,749,302
<TOTAL-LIABILITY-AND-EQUITY>                27,348,772
<SALES>                                              0
<TOTAL-REVENUES>                             2,333,448
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             		880,808
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              1,452,640
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          1,452,640
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,452,640
<EPS-BASIC>                                      .36
<EPS-DILUTED>                                      .36


</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                 6-MOS
<FISCAL-YEAR-END>             DEC-31-1999
<PERIOD-START>                JAN-01-2000
<PERIOD-END>                  JUN-30-2000
<CASH>                        1506000
<SECURITIES>                  0
<RECEIVABLES>                 17437000
<ALLOWANCES>                  (830000)
<INVENTORY>                   0
<CURRENT-ASSETS>              19555000
<PP&E>                        302226000
<DEPRECIATION>                (192771000)
<TOTAL-ASSETS>                167976000
<CURRENT-LIABILITIES>         24628000
<BONDS>                       100000000
<PREFERRED-MANDATORY>         0
<PREFERRED>                   0
<COMMON>                      246000
<OTHER-SE>                    4226000
<TOTAL-LIABILITY-AND-EQUITY>  167976000
<SALES>                       37581000
<TOTAL-REVENUES>              37581000
<CGS>                         0
<TOTAL-COSTS>                 26202000
<OTHER-EXPENSES>              0
<LOSS-PROVISION>              0
<INTEREST-EXPENSE>            7762000
<INCOME-PRETAX>               3617000
<INCOME-TAX>                  (27602000)
<INCOME-CONTINUING>           31219000
<DISCONTINUED>                0
<EXTRAORDINARY>               0
<CHANGES>                     0
<NET-INCOME>                  31219000
<EPS-BASIC>                   1.29
<EPS-DILUTED>                 1.29



</TABLE>
----

----

----

----

|         If to      Employer:         CytRx      Corporation        11726      San Vicente Boulevard, Suite 650        Los      Angeles, California  90049        Facsimile:                                (310)      826-5529        Attention:                                Chief      Executive Officer |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|          If to      Employee:         __________________        __________________        __________________                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

----

|   | “EMPLOYER” CytRx      Corporation  By: /s/ STEVEN A.      KRIEGSMANSteven A.KriegsmanChief Executive      Officer                                                                                                                                                                                                                                                                             |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | “EMPLOYEE”  /s/ JACK      BARBER                                                          Jack      Barber |

----
[Federal Register Volume 87, Number 23 (Thursday, February 3, 2022)]
[Notices]
[Page 6184]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02249]


-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-4634-DR; Docket ID FEMA-2022-0001]


Colorado; Amendment No. 1 to Notice of a Major Disaster 
Declaration

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice amends the notice of a major disaster declaration 
for the State of Colorado (FEMA-4634-DR), dated December 31, 2021, and 
related determinations.

DATES: This amendment was issued January 13, 2022.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and 
Recovery, Federal Emergency Management Agency, 500 C Street SW, 
Washington, DC 20472, (202) 646-2833.

SUPPLEMENTARY INFORMATION: Notice is hereby given that the incident 
period for this disaster is closed effective January 7, 2022.

    The following Catalog of Federal Domestic Assistance Numbers 
(CFDA) are to be used for reporting and drawing funds: 97.030, 
Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis 
Counseling; 97.033, Disaster Legal Services; 97.034, Disaster 
Unemployment Assistance (DUA); 97.046, Fire Management Assistance 
Grant; 97.048, Disaster Housing Assistance to Individuals and 
Households In Presidentially Declared Disaster Areas; 97.049, 
Presidentially Declared Disaster Assistance--Disaster Housing 
Operations for Individuals and Households; 97.050, Presidentially 
Declared Disaster Assistance to Individuals and Households--Other 
Needs; 97.036, Disaster Grants--Public Assistance (Presidentially 
Declared Disasters); 97.039, Hazard Mitigation Grant.

Deanne Criswell,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2022-02249 Filed 2-2-22; 8:45 am]
BILLING CODE 9111-23-P
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1404 Introduced in House (IH)]

<DOC>

117th CONGRESS
  1st Session
                                H. R. 1404

To redesignate the Federal building located at 935 Pennsylvania Avenue 
   Northwest in the District of Columbia as the ``Federal Bureau of 
                       Investigation Building''.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 26, 2021

 Mr. Cohen (for himself, Mr. Carson, Ms. Lee of California, Mr. Rush, 
Mr. Danny K. Davis of Illinois, Mr. Payne, Ms. Moore of Wisconsin, Mr. 
Johnson of Georgia, Ms. Bass, Mr. Hastings, Ms. Pressley, Mr. Thompson 
   of Mississippi, Ms. Wasserman Schultz, Mr. Beyer, Mr. Evans, Mr. 
  Blumenauer, Ms. Norton, Ms. Schakowsky, Mr. Veasey, Mr. Jones, Ms. 
Tlaib, Ms. Clarke of New York, and Mrs. Watson Coleman) introduced the 
 following bill; which was referred to the Committee on Transportation 
                           and Infrastructure

_______________________________________________________________________

                                 A BILL

 
To redesignate the Federal building located at 935 Pennsylvania Avenue 
   Northwest in the District of Columbia as the ``Federal Bureau of 
                       Investigation Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. REDESIGNATION.

    The Federal building located at 935 Pennsylvania Avenue Northwest 
in the District of Columbia, commonly known as the J. Edgar Hoover 
Federal Building, shall be known and designated as the ``Federal Bureau 
of Investigation Building''.

SEC. 2. REFERENCES.

    Any reference in a law, map, regulation, document, paper, or other 
record of the United States to the Federal building referred to in 
section 1 shall be deemed to be a reference to the ``Federal Bureau of 
Investigation Building''.
                                 <all>
```
Timothy Justin TACY, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D17-4918

District Court of Appeal of Florida, Second District.

January 23, 2018

BY ORDER OF THE COURT:

Petitioner's petition for writ of mandamus is denied.

SILBERMAN, KELLY, and BADALAMENTI, JJ., Concur.
Exhibit 31.2



California Micro Devices

Rule 13a-14(a)/15d-14(a) Certification of R. Gregory Miller, Principal Financial Officer



I, R. Gregory Miller, certify that:



1. I have reviewed this Amendment No. 2 on Form 10-K/A (this Amendment) to the Annual Report on Form 10-K for the fiscal year ended March 31, 2003, of
California Micro Devices Corporation, a California corporation; and



2. Based
on my knowledge, this Amendment does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this Amendment;



Date: September 2, 2004



|    |  |                                                                                                             
|--- |  | ------------------------------------------------------------------------------------------------------------
|    | 
|By: |  | /S/ R. GREGORY MILLER                                                                                       
|    |  | R. Gregory Miller, Vice President Finance
& ChiefFinancial Officer (Principal Financial & AccountingOfficer)
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAY-21-2000
<PERIOD-START>                             JUN-01-1999
<PERIOD-END>                               AUG-31-1999
<CASH>                                          20,106
<SECURITIES>                                         0
<RECEIVABLES>                                  543,024
<ALLOWANCES>                                  (20,000)
<INVENTORY>                                    242,665
<CURRENT-ASSETS>                               785,795
<PP&E>                                         209,203
<DEPRECIATION>                               (128,876)
<TOTAL-ASSETS>                              29,904,901
<CURRENT-LIABILITIES>                        1,929,148
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                      1,144
<COMMON>                                       732,716
<OTHER-SE>                                  20,217,059
<TOTAL-LIABILITY-AND-EQUITY>                29,904,901
<SALES>                                        360,441
<TOTAL-REVENUES>                               360,441
<CGS>                                          322,549
<TOTAL-COSTS>                                  322,549
<OTHER-EXPENSES>                               748,934
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              18,596
<INCOME-PRETAX>                              (729,638)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (729,638)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (729,638)
<EPS-BASIC>                                     (0.05)
<EPS-DILUTED>                                   (0.05)


</TABLE>
##### 



EXHIBIT 32.1
 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  
    
    the Quarterly Report of the Company on Form 10-Q for the period ended December 30,
2007 fully complies with the requirements of Section 13(a) and 15(b) of the Securities
Exchange Act of 1934; and
    
    the information contained in the Form 10-Q fairly presents, in all material
respects, the financial condition and results of operation of the Company.
  /s/
Jack H. BrownJack H. BrownChairman, President, and
Chief Executive Officer
(Principal Executive Officer)February 13, 2008 /s/ Phillip J. SmithPhillip J. SmithExecutive Vice President, and
Chief Financial Officer
(Principal Financial Officer)February 13, 2008
<TABLE> <S> <C>


<ARTICLE> 5
<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
FINANCIAL  STATEMENTS  OF TAPISTRON  INTERNATIONAL,  INC.,  FOR THE TWELVE MONTH
PERIOD  ENDED JULY 31,  1997,  AND IS  QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

       

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                      JUL-31-1997
<PERIOD-START>                         AUG-01-1996
<PERIOD-END>                           JUL-31-1997
<CASH>                                          28
<SECURITIES>                                     0
<RECEIVABLES>                                1,071 
<ALLOWANCES>                                    40
<INVENTORY>                                  1,231  
<CURRENT-ASSETS>                             2,532
<PP&E>                                       1,345
<DEPRECIATION>                                 781
<TOTAL-ASSETS>                               5,268
<CURRENT-LIABILITIES>                        1,774
<BONDS>                                          0
<PREFERRED-MANDATORY>                            0
<PREFERRED>                                      0
<COMMON>                                         4
<OTHER-SE>                                     968
<TOTAL-LIABILITY-AND-EQUITY>                 5,268
<SALES>                                      3,626
<TOTAL-REVENUES>                             3,626
<CGS>                                        2,477
<TOTAL-COSTS>                                2,477
<OTHER-EXPENSES>                             2,009
<LOSS-PROVISION>                                 0
<INTEREST-EXPENSE>                              30    
<INCOME-PRETAX>                             (1,683)
<INCOME-TAX>                                (2,000)
<INCOME-CONTINUING>                            316
<DISCONTINUED>                                   0
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                                   316
<EPS-PRIMARY>                                  .03
<EPS-DILUTED>                                  .03


        

</TABLE>
EXHIBIT
32.2

CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Apria
Healthcare Group Inc. (the company or Apria) on Form 10-Q for
the quarter ended June 30, 2006 as filed with the SEC on the date hereof (the
Report), I, Amin I. Khalifa, Executive Vice President and Chief Financial
Officer of the company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant
to § 906 of the Sarbanes-Oxley Act of 2002, that:

|(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and
|--- | -------------------------------------------------------------------------------------------------------------------------------

|(2) | The information contained in the Report fairly presents, in all material
          respects, the financial condition and results of operations of the company.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------

/s/ AMIN I. KHALIFA

 Amin I. Khalifa
Executive Vice President and Chief Financial OfficerAugust 9, 2006

A signed original of this written statement required by Section 906 has been provided to
Apria and will be retained by Apria and furnished to the Securities and Exhange Commission
or its staff upon request.